AstraZeneca
AZN
#67
Rank
NZ$426.61 B
Marketcap
NZ$275.08
Share price
-1.11%
Change (1 day)
2.57%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): NZ$11.96

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$11.75. In 2024 the company made an earnings per share (EPS) of NZ$7.68 an increase over its 2023 EPS that were of NZ$6.49.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$11.96
2024NZ$7.6818.23%
2023NZ$6.4981.13%
2022NZ$3.58631.03%
2021NZ$0.49-88.11%
2020NZ$4.13136.89%
2019NZ$1.74-39.41%
2018NZ$2.87-28.27%
2017NZ$4.01-14.37%
2016NZ$4.6824.11%
2015NZ$3.77127.55%
2014NZ$1.66-51.96%
2013NZ$3.45-58.95%
2012NZ$8.40-32.2%
2011NZ$12.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.77 25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.87 1.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.21-81.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.10-48.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$47.72 306.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.33-63.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$15.81 34.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.04-48.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.02-48.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.57-44.08%๐Ÿ‡ฌ๐Ÿ‡ง UK